|
Case of Relapsed DLBCL |
05/24/2024 - 8:00am to 9:00am EDT |
|
Case on Mycoses Fungoides |
11/15/2024 - 8:00am to 9:00am EST |
|
Case Presentation: A 33-year-old man presenting with anemia and thrombocytosis |
09/16/2022 - 8:00am to 9:00am EDT |
|
CD20 X CD3 Bispecifics-Redefining Treatment for Patients with R/R DLBCL/LBCL |
07/26/2024 - 8:00am to 9:00am EDT |
|
CDK 4/6 Inhibitors in Metastatic Breast Cancer |
05/10/2024 - 8:00am to 9:00am EDT |
|
CDK 4/6 Inhibitors: Practice Changing Implications of Targeted Therapies in HR+/HER2-Breast Cancer |
10/13/2023 - 8:00am to 9:00am EDT |
|
Cell Therapies for Cancer and Beyond |
04/22/2022 - 8:00am to 9:00am EDT |
|
Challenges and Opportunities in Drug Development with Radiation |
11/05/2021 - 8:00am to 9:00am EDT |
|
Changing Paradigm: Evaluating the Use of FLT3 Inhibitors in Patients with AML |
07/12/2024 - 8:00am to 9:00am EDT |
|
Characterizing Severe Chronic Active EBV Infection |
05/28/2021 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward